Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03013478 · ClinicalTrials.gov registry record · NA

Computer Based Training in CBT in Primary Care

A NA study of Substance Abuse, sponsored by Yale University.

Completed
Registry status
NA
Development phase
58
Enrollment target
1
Study location

NCT03013478: Completed NA study of Substance Abuse, sponsored by Yale University.

NCT03013478 is a NA study of Substance Abuse that has completed, run by Yale University. The registered enrollment target is 58 participants, below the 5,259-participant average among 58 other Substance Abuse trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03013478, a NA study of Substance Abuse, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
58 participants
Enrollment target
1
Study location

Study Summary

To conduct an 8-week randomized trial evaluating the feasibility and efficacy of adding CBT4CBT to treatment as usual in a community based primary care program in a population of 60 individuals who meet current DSM criteria for substance use disorder other than nicotine.

Primary Outcome

subjects returning for treatment at primary care unit and completing CBT4CBT program for those assigned

Conditions Studied

Interventions

  • BEHAVIORAL Standard Treatment As Usual (TAU)
  • BEHAVIORAL CBT4CBT program

Study Locations (1)

Connecticut

  • Yale New Haven Hospital St Raphael's Campus - New Haven

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2016-11
Est. Completion 2018-08-31
Phase NA
Yale University

1,492 total trials

What the finished NCT03013478 record still lists

NCT03013478 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 5,259-participant average among 58 other Substance Abuse trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Substance Abuse appearing as the primary indexed condition, and to 2 interventions - of which Standard Treatment As Usual (TAU) is the first listed.

NCT03013478 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT03013478 about?

NCT03013478 is a clinical study titled "Computer Based Training in CBT in Primary Care". To conduct an 8-week randomized trial evaluating the feasibility and efficacy of adding CBT4CBT to treatment as usual in a community based primary care program in a population of 60 individuals who meet current DSM criteria for substance use disorder other than nicotine.

What is the current status of trial NCT03013478?

This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2016-11. Estimated completion is 2018-08-31.

What conditions does trial NCT03013478 study?

This clinical trial studies the following conditions: Substance Abuse.

What interventions are being tested in trial NCT03013478?

The interventions under investigation include: Standard Treatment As Usual (TAU) (BEHAVIORAL), CBT4CBT program (BEHAVIORAL).

Who is sponsoring clinical trial NCT03013478?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03013478 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03013478's enrollment target sits among peer trials

58 49th of 58 higher than 10 of 58 other Substance Abuse trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03587844 · 58 participants · Phase 2

    Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

  • NCT03630991 · 58 participants · Phase 1

    Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

  • NCT03949855 · 58 participants · Phase 2

    Belimumab With Rituximab for Primary Membranous Nephropathy

  • NCT04069273 · 58 participants · Phase 2

    Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03013478, the US trial registry maintained by the National Library of Medicine. NCT03013478 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.